Tower Research Capital LLC (Trc) Acadia Pharmaceuticals Inc Call Options Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$840 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$273 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$236 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$171 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$143 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.17B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...